MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 139 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,356,000 | +14.9% | 18,812 | +3.4% | 0.00% | 0.0% |
| Q4 2018 | $2,051,000 | -63.7% | 18,193 | -31.0% | 0.00% | 0.0% |
| Q3 2018 | $5,644,000 | +72.0% | 26,360 | +124.7% | 0.00% | -25.0% |
| Q2 2018 | $3,281,000 | +206.9% | 11,732 | +28.2% | 0.00% | +300.0% |
| Q1 2018 | $1,069,000 | +60.0% | 9,150 | +25.8% | 0.00% | 0.0% |
| Q4 2017 | $668,000 | +205.0% | 7,274 | +49.3% | 0.00% | – |
| Q3 2017 | $219,000 | +177.2% | 4,871 | 0.0% | 0.00% | – |
| Q2 2017 | $79,000 | – | 4,871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |